Literature DB >> 15541772

Senescent fibroblasts resist apoptosis by downregulating caspase-3.

Richard Marcotte1, Chantale Lacelle, Eugenia Wang.   

Abstract

In replicative senescence, cells undergo permanent exit from cell cycle traverse; this is traditionally thought to occur at the end of a culture's in vitro life span, after serial passaging. In general, the checkpoint for replicative senescence is found at the G(1)/S border, controlled by the modulation of a battery of proteins, typified by gaining inhibitors of cell cycle traverse, such as cyclin-dependent kinases or RB hyperphosphorylation, and losing pro-proliferation gene expressions such as c-fos, c-myc, and a cadre of proliferation-dependent kinases. Here, we present evidence that replicatively senescent fibroblasts are resistant to apoptotic death, associated with a lack of key enzyme activities, caspase-3 being the chief executioner. This observation, coupled with our earlier report that senescent fibroblasts maintain persistently high levels of pro-survival factor Bcl-2, suggests that the molecular signaling program present in fibroblasts at the end of their in vitro life span may not only cater to the state of permanent exit from cell cycle traverse, but also dictate an inability to commit cellular suicide. Future experiments will reveal whether replicatively senescent fibroblasts that can neither proliferate nor die contribute to organismic aging, and whether their accumulation over time in tissue becomes detrimental to the normal aging process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15541772     DOI: 10.1016/j.mad.2004.07.007

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  47 in total

1.  DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation.

Authors:  Olga Moiseeva; Frédérick A Mallette; Utpal K Mukhopadhyay; Adrian Moores; Gerardo Ferbeyre
Journal:  Mol Biol Cell       Date:  2006-01-25       Impact factor: 4.138

2.  Cellular senescence, ageing and disease.

Authors:  D G A Burton
Journal:  Age (Dordr)       Date:  2008-09-04

Review 3.  Molecular processes that drive cigarette smoke-induced epithelial cell fate of the lung.

Authors:  Toru Nyunoya; Yohannes Mebratu; Amelia Contreras; Monica Delgado; Hitendra S Chand; Yohannes Tesfaigzi
Journal:  Am J Respir Cell Mol Biol       Date:  2014-03       Impact factor: 6.914

Review 4.  Mitochondrial maintenance failure in aging and role of sexual dimorphism.

Authors:  John Tower
Journal:  Arch Biochem Biophys       Date:  2014-10-25       Impact factor: 4.013

Review 5.  Senescence and apoptosis: dueling or complementary cell fates?

Authors:  Bennett G Childs; Darren J Baker; James L Kirkland; Judith Campisi; Jan M van Deursen
Journal:  EMBO Rep       Date:  2014-10-13       Impact factor: 8.807

Review 6.  Cellular senescence: from growth arrest to immunogenic conversion.

Authors:  D G A Burton; R G A Faragher
Journal:  Age (Dordr)       Date:  2015-03-20

Review 7.  Myofibroblast differentiation and survival in fibrotic disease.

Authors:  Kornelia Kis; Xiaoqiu Liu; James S Hagood
Journal:  Expert Rev Mol Med       Date:  2011-08-23       Impact factor: 5.600

Review 8.  Programmed cell death in aging.

Authors:  John Tower
Journal:  Ageing Res Rev       Date:  2015-04-08       Impact factor: 10.895

9.  Proteomic analysis reveals a role for Bcl2-associated athanogene 3 and major vault protein in resistance to apoptosis in senescent cells by regulating ERK1/2 activation.

Authors:  Martina P Pasillas; Sarah Shields; Rebecca Reilly; Jan Strnadel; Christian Behl; Robin Park; John R Yates; Richard Klemke; Steven L Gonias; Judith A Coppinger
Journal:  Mol Cell Proteomics       Date:  2014-07-05       Impact factor: 5.911

10.  The ATM and ATR inhibitors CGK733 and caffeine suppress cyclin D1 levels and inhibit cell proliferation.

Authors:  John P Alao; Per Sunnerhagen
Journal:  Radiat Oncol       Date:  2009-11-10       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.